Abbott Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABBOTT, and what generic and branded alternatives to ABBOTT drugs are available?
ABBOTT has one hundred and eleven approved drugs.
Drugs and US Patents for Abbott
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott | BRETYLIUM TOSYLATE IN DEXTROSE 5% | bretylium tosylate | INJECTABLE;INJECTION | 019005-003 | Apr 29, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Abbott | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 089362-001 | May 25, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Abbott | SODIUM BICARBONATE IN PLASTIC CONTAINER | sodium bicarbonate | INJECTABLE;INJECTION | 019443-002 | Jun 3, 1986 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Abbott | LIPOSYN 20% | safflower oil | INJECTABLE;INJECTION | 018614-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Abbott
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbott | NORVIR | ritonavir | CAPSULE;ORAL | 020680-001 | Mar 1, 1996 | 5,948,436*PED | ⤷ Try a Trial |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-001 | Aug 7, 1987 | 4,251,532 | ⤷ Try a Trial |
Abbott | HYTRIN | terazosin hydrochloride | CAPSULE;ORAL | 020347-002 | Dec 14, 1994 | 5,294,615 | ⤷ Try a Trial |
Abbott | MERIDIA | sibutramine hydrochloride | CAPSULE;ORAL | 020632-002 | Nov 22, 1997 | 4,746,680*PED | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ABBOTT drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 10 mg and 15 mg | ➤ Subscribe | 2009-08-14 |
➤ Subscribe | Capsules | 100 mg | ➤ Subscribe | 2012-10-31 |
➤ Subscribe | Tablets | 100 mg | ➤ Subscribe | 2010-12-21 |
Similar Applicant Names
Here is a list of applicants with similar names.